Antiretroviral Therapy, Highly Active
"Antiretroviral Therapy, Highly Active" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
Descriptor ID |
D023241
|
MeSH Number(s) |
E02.319.310.075
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antiretroviral Therapy, Highly Active".
Below are MeSH descriptors whose meaning is more specific than "Antiretroviral Therapy, Highly Active".
This graph shows the total number of publications written about "Antiretroviral Therapy, Highly Active" by people in UAMS Profiles by year, and whether "Antiretroviral Therapy, Highly Active" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2020 | 1 | 1 | 2 | 2018 | 0 | 1 | 1 | 2015 | 2 | 1 | 3 | 2014 | 1 | 1 | 2 | 2013 | 1 | 2 | 3 | 2012 | 1 | 0 | 1 | 2011 | 2 | 1 | 3 | 2010 | 1 | 1 | 2 | 2009 | 0 | 1 | 1 | 2008 | 1 | 0 | 1 | 2007 | 1 | 2 | 3 | 2006 | 0 | 2 | 2 | 2004 | 1 | 0 | 1 | 2002 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Antiretroviral Therapy, Highly Active" by people in Profiles over the past ten years.
-
Leffert J, Purushothaman R, Vilanilam GK, Stanley M, Kothari A. HIV-vacuolar myelopathy: an unusual early presentation in HIV. Int J STD AIDS. 2021 02; 32(2):205-208.
-
Callen AL, Dupont SM, Pyne J, Talbott J, Tien P, Calabrese E, Saloner D, Chow FC, Narvid J. The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women. J Neurovirol. 2020 10; 26(5):734-742.
-
Pei Q, Han X, Zhang Y, Zhang W, Zhou DB. [Clinical Analysis of 10 Cases of AIDS Complicated with Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Feb; 26(1):146-152.
-
Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W, Chadburn A. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016 07; 57(7):1731-4.
-
Thao VP, Quang VM, Day JN, Chinh NT, Shikuma CM, Farrar J, Van Vinh Chau N, Thwaites GE, Dunstan SJ, Le T. High prevalence of PI resistance in patients failing second-line ART in Vietnam. J Antimicrob Chemother. 2016 Mar; 71(3):762-74.
-
Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 2015 Jul 09; 126(2):160-6.
-
Sacktor N, Miyahara S, Evans S, Schifitto G, Cohen B, Haughey N, Drewes JL, Graham D, Zink MC, Anderson C, Nath A, Pardo CA, McCarthy S, Hosey L, Clifford D. Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. J Neurovirol. 2014 Dec; 20(6):620-6.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|